SIMILAR PATTERNS OF AMINO ACIDS FOR 6BSI_A_EFZA601

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1f2p AMINOPEPTIDASE

(Streptomyces
griseus)
PF04389
(Peptidase_M28)
5 LEU A 153
VAL A 211
TYR A 156
GLY A 212
LEU A 145
None
1.35A 6bsiA-1f2pA:
undetectable
6bsiA-1f2pA:
13.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1har HIV-1 REVERSE
TRANSCRIPTASE
(FINGERS AND PALM
SUBDOMAINS)


(Human
immunodeficiency
virus 1)
PF00078
(RVT_1)
5 LYS A 104
VAL A 179
TYR A 181
TYR A 188
GLY A 190
None
1.10A 6bsiA-1harA:
24.0
6bsiA-1harA:
91.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1vm6 DIHYDRODIPICOLINATE
REDUCTASE


(Thermotoga
maritima)
PF01113
(DapB_N)
PF05173
(DapB_C)
5 VAL A  45
VAL A  90
TYR A  64
GLY A  67
LEU A  60
None
1.23A 6bsiA-1vm6A:
undetectable
6bsiA-1vm6A:
15.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1w78 FOLC BIFUNCTIONAL
PROTEIN


(Escherichia
coli)
PF02875
(Mur_ligase_C)
PF08245
(Mur_ligase_M)
5 LEU A 134
VAL A 143
VAL A  95
TYR A  81
GLY A  79
None
1.29A 6bsiA-1w78A:
0.0
6bsiA-1w78A:
12.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1w78 FOLC BIFUNCTIONAL
PROTEIN


(Escherichia
coli)
PF02875
(Mur_ligase_C)
PF08245
(Mur_ligase_M)
5 VAL A 143
VAL A  95
TYR A  81
GLY A  79
LEU A 132
None
1.30A 6bsiA-1w78A:
0.0
6bsiA-1w78A:
12.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1yf2 TYPE I
RESTRICTION-MODIFICA
TION ENZYME, S
SUBUNIT


(Methanocaldococcus
jannaschii)
PF01420
(Methylase_S)
5 LEU A 368
VAL A 311
VAL A 308
GLY A 309
LEU A 327
None
1.22A 6bsiA-1yf2A:
0.0
6bsiA-1yf2A:
11.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1yq9 PERIPLASMIC [NIFE]
HYDROGENASE SMALL
SUBUNIT


(Desulfovibrio
gigas)
PF01058
(Oxidored_q6)
PF14720
(NiFe_hyd_SSU_C)
5 LEU A  60
VAL A  87
GLY A  88
LEU A  12
TYR A  44
GOL  A1272 (-4.0A)
None
GOL  A1271 (-3.8A)
None
None
1.27A 6bsiA-1yq9A:
undetectable
6bsiA-1yq9A:
16.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2b4g DIHYDROOROTATE
DEHYDROGENASE


(Trypanosoma
brucei)
PF01180
(DHO_dh)
5 LEU A 231
VAL A 252
VAL A 226
GLY A 250
LEU A 260
None
None
None
FMN  A1400 (-3.3A)
None
1.49A 6bsiA-2b4gA:
0.3
6bsiA-2b4gA:
12.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2b4g DIHYDROOROTATE
DEHYDROGENASE


(Trypanosoma
brucei)
PF01180
(DHO_dh)
5 LEU A 231
VAL A 252
VAL A 226
GLY A 251
LEU A 260
None
None
None
FMN  A1400 (-3.9A)
None
1.29A 6bsiA-2b4gA:
0.3
6bsiA-2b4gA:
12.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2c4m GLYCOGEN
PHOSPHORYLASE


(Corynebacterium
callunae)
PF00343
(Phosphorylase)
5 LEU A 535
VAL A 688
TYR A 685
GLY A 690
LEU A 733
None
1.35A 6bsiA-2c4mA:
2.6
6bsiA-2c4mA:
7.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2dvu THERMOPHILIC
REVERSIBLE
GAMMA-RESORCYLATE
DECARBOXYLASE


(Rhizobium sp.
MTP-10005)
PF04909
(Amidohydro_2)
5 LEU A 321
VAL A 159
TYR A 162
GLY A 124
LEU A   7
None
1.47A 6bsiA-2dvuA:
undetectable
6bsiA-2dvuA:
14.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2f8t ARGONAUTE PROTEIN

(Aquifex
aeolicus)
PF02171
(Piwi)
5 LEU A 528
VAL A 499
TYR A 531
TYR A 532
GLY A 500
None
1.24A 6bsiA-2f8tA:
2.5
6bsiA-2f8tA:
8.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2g02 NISIN BIOSYNTHESIS
PROTEIN NISC


(Lactococcus
lactis)
PF05147
(LANC_like)
5 LEU A 412
VAL A 307
TYR A 296
GLY A 298
LEU A 346
None
1.36A 6bsiA-2g02A:
undetectable
6bsiA-2g02A:
13.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2hnz REVERSE
TRANSCRIPTASE/RIBONU
CLEASE H


(Human
immunodeficiency
virus 1)
PF00075
(RNase_H)
PF00078
(RVT_1)
PF06815
(RVT_connect)
PF06817
(RVT_thumb)
7 LEU A 100
LYS A 103
TYR A 181
GLY A 190
TRP A 229
LEU A 234
TYR A 318
PC0  A 999 ( 3.9A)
None
PC0  A 999 (-3.9A)
PC0  A 999 ( 4.8A)
PC0  A 999 ( 4.2A)
PC0  A 999 (-4.2A)
PC0  A 999 (-4.3A)
0.75A 6bsiA-2hnzA:
35.9
6bsiA-2hnzA:
98.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2hnz REVERSE
TRANSCRIPTASE/RIBONU
CLEASE H


(Human
immunodeficiency
virus 1)
PF00075
(RNase_H)
PF00078
(RVT_1)
PF06815
(RVT_connect)
PF06817
(RVT_thumb)
7 LEU A 100
LYS A 103
TYR A 181
TYR A 188
GLY A 190
TRP A 229
TYR A 318
PC0  A 999 ( 3.9A)
None
PC0  A 999 (-3.9A)
PC0  A 999 (-4.1A)
PC0  A 999 ( 4.8A)
PC0  A 999 ( 4.2A)
PC0  A 999 (-4.3A)
0.89A 6bsiA-2hnzA:
35.9
6bsiA-2hnzA:
98.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2hnz REVERSE
TRANSCRIPTASE/RIBONU
CLEASE H


(Human
immunodeficiency
virus 1)
PF00075
(RNase_H)
PF00078
(RVT_1)
PF06815
(RVT_connect)
PF06817
(RVT_thumb)
6 LEU A 100
LYS A 103
VAL A 106
GLY A 190
LEU A 234
TYR A 318
PC0  A 999 ( 3.9A)
None
PC0  A 999 ( 4.8A)
PC0  A 999 ( 4.8A)
PC0  A 999 (-4.2A)
PC0  A 999 (-4.3A)
0.81A 6bsiA-2hnzA:
35.9
6bsiA-2hnzA:
98.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2hnz REVERSE
TRANSCRIPTASE/RIBONU
CLEASE H


(Human
immunodeficiency
virus 1)
PF00075
(RNase_H)
PF00078
(RVT_1)
PF06815
(RVT_connect)
PF06817
(RVT_thumb)
6 LEU A 100
LYS A 103
VAL A 106
TYR A 188
GLY A 190
TYR A 318
PC0  A 999 ( 3.9A)
None
PC0  A 999 ( 4.8A)
PC0  A 999 (-4.1A)
PC0  A 999 ( 4.8A)
PC0  A 999 (-4.3A)
0.86A 6bsiA-2hnzA:
35.9
6bsiA-2hnzA:
98.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2hnz REVERSE
TRANSCRIPTASE/RIBONU
CLEASE H


(Human
immunodeficiency
virus 1)
PF00075
(RNase_H)
PF00078
(RVT_1)
PF06815
(RVT_connect)
PF06817
(RVT_thumb)
6 LEU A 100
VAL A 106
VAL A 179
GLY A 190
LEU A 234
TYR A 318
PC0  A 999 ( 3.9A)
PC0  A 999 ( 4.8A)
PC0  A 999 (-4.4A)
PC0  A 999 ( 4.8A)
PC0  A 999 (-4.2A)
PC0  A 999 (-4.3A)
0.64A 6bsiA-2hnzA:
35.9
6bsiA-2hnzA:
98.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2hnz REVERSE
TRANSCRIPTASE/RIBONU
CLEASE H


(Human
immunodeficiency
virus 1)
PF00075
(RNase_H)
PF00078
(RVT_1)
PF06815
(RVT_connect)
PF06817
(RVT_thumb)
6 LEU A 100
VAL A 106
VAL A 179
TYR A 188
GLY A 190
TYR A 318
PC0  A 999 ( 3.9A)
PC0  A 999 ( 4.8A)
PC0  A 999 (-4.4A)
PC0  A 999 (-4.1A)
PC0  A 999 ( 4.8A)
PC0  A 999 (-4.3A)
0.72A 6bsiA-2hnzA:
35.9
6bsiA-2hnzA:
98.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2hnz REVERSE
TRANSCRIPTASE/RIBONU
CLEASE H


(Human
immunodeficiency
virus 1)
PF00075
(RNase_H)
PF00078
(RVT_1)
PF06815
(RVT_connect)
PF06817
(RVT_thumb)
7 LEU A 100
VAL A 179
TYR A 181
GLY A 190
TRP A 229
LEU A 234
TYR A 318
PC0  A 999 ( 3.9A)
PC0  A 999 (-4.4A)
PC0  A 999 (-3.9A)
PC0  A 999 ( 4.8A)
PC0  A 999 ( 4.2A)
PC0  A 999 (-4.2A)
PC0  A 999 (-4.3A)
0.58A 6bsiA-2hnzA:
35.9
6bsiA-2hnzA:
98.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2hnz REVERSE
TRANSCRIPTASE/RIBONU
CLEASE H


(Human
immunodeficiency
virus 1)
PF00075
(RNase_H)
PF00078
(RVT_1)
PF06815
(RVT_connect)
PF06817
(RVT_thumb)
7 LEU A 100
VAL A 179
TYR A 181
TYR A 188
GLY A 190
TRP A 229
TYR A 318
PC0  A 999 ( 3.9A)
PC0  A 999 (-4.4A)
PC0  A 999 (-3.9A)
PC0  A 999 (-4.1A)
PC0  A 999 ( 4.8A)
PC0  A 999 ( 4.2A)
PC0  A 999 (-4.3A)
0.74A 6bsiA-2hnzA:
35.9
6bsiA-2hnzA:
98.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2jbm NICOTINATE-NUCLEOTID
E PYROPHOSPHORYLASE


(Homo sapiens)
PF01729
(QRPTase_C)
PF02749
(QRPTase_N)
5 LEU A 110
VAL A 156
VAL A 149
TRP A  75
LEU A  56
None
1.33A 6bsiA-2jbmA:
4.3
6bsiA-2jbmA:
11.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qjo BIFUNCTIONAL NMN
ADENYLYLTRANSFERASE/
NUDIX HYDROLASE


(Synechocystis
sp. PCC 6803)
PF00293
(NUDIX)
PF01467
(CTP_transf_like)
5 LEU A  27
VAL A  35
VAL A 107
TYR A  10
GLY A   8
None
None
None
NAD  A 601 (-4.6A)
None
1.12A 6bsiA-2qjoA:
undetectable
6bsiA-2qjoA:
12.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2w2g NON-STRUCTURAL
PROTEIN 3


(Severe acute
respiratory
syndrome-related
coronavirus)
PF11633
(SUD-M)
5 LEU A 475
VAL A 448
VAL A 445
GLY A 446
LEU A 412
None
1.45A 6bsiA-2w2gA:
undetectable
6bsiA-2w2gA:
17.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2w3p BENZOYL-COA-DIHYDROD
IOL LYASE


(Paraburkholderia
xenovorans)
PF00378
(ECH_1)
5 LEU A 172
VAL A 534
TYR A 543
GLY A 538
LEU A  99
None
1.15A 6bsiA-2w3pA:
undetectable
6bsiA-2w3pA:
8.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wqd PHOSPHOENOLPYRUVATE-
PROTEIN
PHOSPHOTRANSFERASE


(Staphylococcus
aureus)
PF00391
(PEP-utilizers)
PF02896
(PEP-utilizers_C)
PF05524
(PEP-utilisers_N)
5 LEU A 323
LYS A 329
TYR A 297
GLY A 293
LEU A 388
None
1.29A 6bsiA-2wqdA:
undetectable
6bsiA-2wqdA:
10.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wsm HYDROGENASE
EXPRESSION/FORMATION
PROTEIN (HYPB)


(Archaeoglobus
fulgidus)
PF02492
(cobW)
5 LEU A 113
VAL A  58
GLY A  55
TRP A 204
LEU A 208
None
1.49A 6bsiA-2wsmA:
undetectable
6bsiA-2wsmA:
20.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2yv4 HYPOTHETICAL PROTEIN
PH0435


(Pyrococcus
horikoshii)
PF03481
(SUA5)
5 LEU A 262
VAL A 271
VAL A 308
GLY A 270
LEU A 258
None
1.20A 6bsiA-2yv4A:
undetectable
6bsiA-2yv4A:
26.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3any ETHANOLAMINE
AMMONIA-LYASE HEAVY
CHAIN


(Escherichia
coli)
PF06751
(EutB)
5 LEU A 206
VAL A 189
VAL A 192
GLY A 191
TYR A 210
None
1.22A 6bsiA-3anyA:
undetectable
6bsiA-3anyA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3aqu AT4G19810

(Arabidopsis
thaliana)
PF00704
(Glyco_hydro_18)
5 LEU A 130
VAL A  42
TYR A  82
TRP A 115
LEU A 113
None
1.36A 6bsiA-3aquA:
undetectable
6bsiA-3aquA:
11.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3cp2 TRNA URIDINE
5-CARBOXYMETHYLAMINO
METHYL MODIFICATION
ENZYME GIDA


(Escherichia
coli)
PF01134
(GIDA)
PF13932
(GIDA_assoc)
5 LEU A 389
VAL A 458
VAL A  63
GLY A  67
LEU A 455
None
1.38A 6bsiA-3cp2A:
undetectable
6bsiA-3cp2A:
6.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3czp PUTATIVE
POLYPHOSPHATE KINASE
2


(Pseudomonas
aeruginosa)
PF03976
(PPK2)
5 LYS A  54
TYR A 109
GLY A  48
TRP A 108
LEU A  45
None
1.42A 6bsiA-3czpA:
undetectable
6bsiA-3czpA:
9.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3dd6 RIBONUCLEASE PH

(Bacillus
anthracis)
PF01138
(RNase_PH)
PF03725
(RNase_PH_C)
5 LEU A 215
VAL A 164
VAL A 186
GLY A 165
LEU A 219
None
1.21A 6bsiA-3dd6A:
undetectable
6bsiA-3dd6A:
16.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3e81 ACYLNEURAMINATE
CYTIDYLYLTRANSFERASE


(Bacteroides
thetaiotaomicron)
PF08282
(Hydrolase_3)
5 LEU A   8
VAL A  70
TYR A  72
LEU A  53
TYR A 100
None
1.50A 6bsiA-3e81A:
undetectable
6bsiA-3e81A:
21.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3eay SENTRIN-SPECIFIC
PROTEASE 7


(Homo sapiens)
PF02902
(Peptidase_C48)
5 LYS A 681
VAL A 696
TYR A 685
GLY A 695
LEU A 974
None
1.35A 6bsiA-3eayA:
undetectable
6bsiA-3eayA:
13.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3egw RESPIRATORY NITRATE
REDUCTASE 1 ALPHA
CHAIN


(Escherichia
coli)
PF00384
(Molybdopterin)
PF01568
(Molydop_binding)
PF14710
(Nitr_red_alph_N)
5 LEU A 214
VAL A 185
GLY A 211
LEU A 709
TYR A 610
None
1.45A 6bsiA-3egwA:
undetectable
6bsiA-3egwA:
6.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3g9k CAPSULE BIOSYNTHESIS
PROTEIN CAPD


(Bacillus
anthracis)
no annotation 5 LEU L 273
VAL L 261
VAL L 328
TYR L 256
GLY L 254
None
1.33A 6bsiA-3g9kL:
undetectable
6bsiA-3g9kL:
16.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gue UTP-GLUCOSE-1-PHOSPH
ATE
URIDYLYLTRANSFERASE
2


(Trypanosoma
brucei)
PF01704
(UDPGP)
5 LEU A 323
VAL A 193
VAL A 349
GLY A 191
LEU A 312
None
None
DTU  A 489 (-4.2A)
None
None
1.40A 6bsiA-3gueA:
undetectable
6bsiA-3gueA:
11.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ii7 KELCH-LIKE PROTEIN 7

(Homo sapiens)
PF01344
(Kelch_1)
5 LEU A 546
VAL A 521
VAL A 498
GLY A 487
LEU A 542
None
1.45A 6bsiA-3ii7A:
undetectable
6bsiA-3ii7A:
15.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3l15 TRANSCRIPTIONAL
ENHANCER FACTOR
TEF-4


(Homo sapiens)
no annotation 5 VAL A 252
VAL A 329
TYR A 327
TRP A 308
LEU A 306
None
1.47A 6bsiA-3l15A:
undetectable
6bsiA-3l15A:
17.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lz8 PUTATIVE CHAPERONE
DNAJ


(Klebsiella
pneumoniae)
PF01556
(DnaJ_C)
5 LEU A 127
VAL A 258
VAL A 167
GLY A 166
LEU A 210
None
1.34A 6bsiA-3lz8A:
undetectable
6bsiA-3lz8A:
12.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3nks PROTOPORPHYRINOGEN
OXIDASE


(Homo sapiens)
PF01593
(Amino_oxidase)
5 LEU A 401
VAL A 335
VAL A 367
GLY A 345
LEU A 105
None
None
None
ACJ  A 478 (-3.6A)
None
1.30A 6bsiA-3nksA:
undetectable
6bsiA-3nksA:
9.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3s4t AMIDOHYDROLASE 2

(Polaromonas sp.
JS666)
PF04909
(Amidohydro_2)
5 LEU A 321
VAL A 159
TYR A 162
GLY A 124
LEU A   7
None
1.47A 6bsiA-3s4tA:
undetectable
6bsiA-3s4tA:
11.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ta6 TRIOSEPHOSPHATE
ISOMERASE


(Mycobacterium
tuberculosis)
PF00121
(TIM)
5 LEU A 243
VAL A  43
VAL A 238
GLY A   9
LEU A  15
None
1.21A 6bsiA-3ta6A:
undetectable
6bsiA-3ta6A:
12.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3tl8 EFFECTOR PROTEIN
HOPAB2


(Pseudomonas
syringae group
genomosp. 3)
PF16847
(AvrPtoB_bdg)
5 LEU B 344
VAL B 290
VAL B 324
GLY B 288
LEU B 348
None
1.38A 6bsiA-3tl8B:
undetectable
6bsiA-3tl8B:
20.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3uit INAD-LIKE PROTEIN,
MAGUK P55 SUBFAMILY
MEMBER 5, PROTEIN
LIN-7 HOMOLOG B


(Homo sapiens;
Mus musculus;
Rattus
norvegicus)
PF02828
(L27)
PF09045
(L27_2)
PF09060
(L27_N)
5 LEU A 178
VAL A 185
VAL A 196
TYR A 253
GLY A 193
None
1.30A 6bsiA-3uitA:
2.1
6bsiA-3uitA:
14.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3w4r CHITINASE

(Ostrinia
furnacalis)
PF00704
(Glyco_hydro_18)
5 LEU A 145
VAL A 128
VAL A 118
TYR A 114
LEU A 143
None
1.47A 6bsiA-3w4rA:
undetectable
6bsiA-3w4rA:
10.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3wfz LACTO-N-BIOSE
PHOSPHORYLASE


(Bifidobacterium
longum)
PF09508
(Lact_bio_phlase)
PF17385
(LBP_M)
PF17386
(LBP_C)
5 LEU A 680
VAL A 665
VAL A 542
GLY A 541
LEU A 684
None
1.40A 6bsiA-3wfzA:
undetectable
6bsiA-3wfzA:
7.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3wl1 CHITINASE

(Ostrinia
furnacalis)
PF00704
(Glyco_hydro_18)
5 LEU A 145
VAL A 128
VAL A 118
TYR A 114
LEU A 143
None
1.45A 6bsiA-3wl1A:
undetectable
6bsiA-3wl1A:
14.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4dlq LATROPHILIN-1

(Rattus
norvegicus)
PF01825
(GPS)
PF02793
(HRM)
PF16489
(GAIN)
5 LEU A 651
VAL A 679
VAL A 620
TRP A 636
LEU A 733
None
1.48A 6bsiA-4dlqA:
undetectable
6bsiA-4dlqA:
9.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4f1h TYROSYL-DNA
PHOSPHODIESTERASE 2


(Danio rerio)
PF03372
(Exo_endo_phos)
5 LEU A 170
TYR A 177
GLY A 190
LEU A 145
TYR A 166
None
1.38A 6bsiA-4f1hA:
undetectable
6bsiA-4f1hA:
15.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4f92 U5 SMALL NUCLEAR
RIBONUCLEOPROTEIN
200 KDA HELICASE


(Homo sapiens)
PF00270
(DEAD)
PF00271
(Helicase_C)
PF02889
(Sec63)
5 LEU B1597
VAL B1617
VAL B1632
GLY B1618
LEU B1590
None
1.33A 6bsiA-4f92B:
1.2
6bsiA-4f92B:
4.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4jgg ESTERASE TESA

(Pseudomonas
aeruginosa)
PF13472
(Lipase_GDSL_2)
5 LEU A 176
VAL A  39
TYR A  35
TYR A  37
LEU A  67
None
1.28A 6bsiA-4jggA:
undetectable
6bsiA-4jggA:
18.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4jxb INVASION-ASSOCIATED
PROTEIN


(Mycobacterium
tuberculosis)
PF00877
(NLPC_P60)
5 LEU A  96
VAL A 108
GLY A 109
LEU A 167
TYR A  91
None
1.23A 6bsiA-4jxbA:
undetectable
6bsiA-4jxbA:
22.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4kru AUTOLYTIC LYSOZYME

(Clostridium
phage phiSM101)
PF01183
(Glyco_hydro_25)
5 VAL A 124
VAL A 133
TYR A  66
LEU A  86
TYR A  94
None
None
NDG  A 501 (-3.9A)
None
None
1.39A 6bsiA-4kruA:
undetectable
6bsiA-4kruA:
16.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4lec PROTEIN-LYSINE
METHYLTRANSFERASE
METTL21A


(Homo sapiens)
PF10294
(Methyltransf_16)
5 LEU A 139
VAL A  79
VAL A  90
GLY A  80
LEU A 170
None
1.49A 6bsiA-4lecA:
undetectable
6bsiA-4lecA:
13.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4m5p NADPH DEHYDROGENASE

(Scheffersomyces
stipitis)
PF00724
(Oxidored_FMN)
5 LEU A 165
VAL A 132
GLY A 116
LEU A 195
TYR A 170
None
1.43A 6bsiA-4m5pA:
undetectable
6bsiA-4m5pA:
11.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4mhu ECTOINE HYDROXYLASE

(Sphingopyxis
alaskensis)
PF05721
(PhyH)
5 LEU A 105
VAL A 236
VAL A  58
GLY A 234
LEU A 261
None
1.36A 6bsiA-4mhuA:
undetectable
6bsiA-4mhuA:
10.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4pvv ADENOSINE KINASE

(Mycobacterium
tuberculosis)
PF00294
(PfkB)
5 LEU A  81
VAL A  64
VAL A  59
GLY A  58
LEU A  66
None
1.26A 6bsiA-4pvvA:
undetectable
6bsiA-4pvvA:
13.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wd9 NISIN BIOSYNTHESIS
PROTEIN NISB


(Lactococcus
lactis)
PF04738
(Lant_dehydr_N)
PF14028
(Lant_dehydr_C)
5 VAL A  13
VAL A 101
GLY A 100
LEU A 438
TYR A 108
None
1.50A 6bsiA-4wd9A:
4.1
6bsiA-4wd9A:
6.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wjs RSA4

(Chaetomium
thermophilum)
PF00400
(WD40)
5 LEU A 442
VAL A 449
GLY A 423
TRP A 454
LEU A 430
None
1.41A 6bsiA-4wjsA:
undetectable
6bsiA-4wjsA:
12.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4y9a TRIOSEPHOSPHATE
ISOMERASE


(Streptomyces
coelicolor)
PF00121
(TIM)
5 LEU A 247
VAL A  47
VAL A 242
GLY A  13
LEU A  19
None
1.17A 6bsiA-4y9aA:
undetectable
6bsiA-4y9aA:
14.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4yru NEURONAL CALCIUM
SENSOR 1


(Rattus
norvegicus)
PF00036
(EF-hand_1)
PF13499
(EF-hand_7)
5 LYS A 100
VAL A  91
GLY A  95
TRP A  30
LEU A  89
None
1.44A 6bsiA-4yruA:
undetectable
6bsiA-4yruA:
21.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5c24 HIV-1 REVERSE
TRANSCRIPTASE, P51
SUBUNIT


(Human
immunodeficiency
virus 1)
PF00078
(RVT_1)
PF06815
(RVT_connect)
PF06817
(RVT_thumb)
5 LYS B 103
VAL B 106
VAL B 179
TYR B 188
GLY B 190
None
1.07A 6bsiA-5c24B:
11.2
6bsiA-5c24B:
98.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5c24 HIV-1 REVERSE
TRANSCRIPTASE, P51
SUBUNIT


(Human
immunodeficiency
virus 1)
PF00078
(RVT_1)
PF06815
(RVT_connect)
PF06817
(RVT_thumb)
5 LYS B 103
VAL B 179
TYR B 181
TYR B 188
GLY B 190
None
0.82A 6bsiA-5c24B:
11.2
6bsiA-5c24B:
98.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5cbm M17 FAMILY
AMINOPEPTIDASE


(Plasmodium
falciparum)
PF00883
(Peptidase_M17)
5 LEU A 297
VAL A 593
GLY A 590
LEU A 407
TYR A 293
None
1.36A 6bsiA-5cbmA:
1.9
6bsiA-5cbmA:
10.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5czz CRISPR-ASSOCIATED
ENDONUCLEASE CAS9


(Staphylococcus
aureus)
PF13395
(HNH_4)
PF16592
(Cas9_REC)
5 LEU A 205
LYS A 181
TYR A 176
LEU A 112
TYR A 201
None
1.43A 6bsiA-5czzA:
5.2
6bsiA-5czzA:
7.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5e7p CELL DIVISION
CONTROL PROTEIN
CDC48


(Mycolicibacterium
smegmatis)
PF00004
(AAA)
PF02359
(CDC48_N)
5 LEU A 640
VAL A 522
TYR A 525
GLY A 627
LEU A 648
None
1.36A 6bsiA-5e7pA:
undetectable
6bsiA-5e7pA:
7.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5fg9 PROTEASOME SUBUNIT
BETA TYPE-2


(Saccharomyces
cerevisiae)
PF00227
(Proteasome)
PF12465
(Pr_beta_C)
5 LEU H 154
VAL H  13
VAL H   4
GLY H   5
LEU H 146
None
1.47A 6bsiA-5fg9H:
undetectable
6bsiA-5fg9H:
19.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5fg9 PROTEASOME SUBUNIT
BETA TYPE-2


(Saccharomyces
cerevisiae)
PF00227
(Proteasome)
PF12465
(Pr_beta_C)
5 LEU H 154
VAL H  13
VAL H   4
TYR H 124
LEU H 146
None
0.99A 6bsiA-5fg9H:
undetectable
6bsiA-5fg9H:
19.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5g51 DWV-VP3-P-DOMAIN

(Deformed wing
virus)
no annotation 5 LEU A 364
VAL A 332
VAL A 286
GLY A 342
LEU A 358
None
1.30A 6bsiA-5g51A:
undetectable
6bsiA-5g51A:
20.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5kuf GLUTAMATE RECEPTOR
IONOTROPIC, KAINATE
2


(Rattus
norvegicus)
PF00060
(Lig_chan)
PF01094
(ANF_receptor)
PF10613
(Lig_chan-Glu_bd)
5 LEU A 435
VAL A 735
GLY A 734
LEU A 760
TYR A 431
None
1.06A 6bsiA-5kufA:
undetectable
6bsiA-5kufA:
6.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5mg5 HYDROXYMETHYLGLUTARY
L-COA SYNTHASE


(Pseudomonas
protegens)
no annotation 5 LEU A 288
VAL A 240
TYR A 238
GLY A 283
TYR A  11
None
1.43A 6bsiA-5mg5A:
undetectable
6bsiA-5mg5A:
20.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5n6v AMYLOSUCRASE

(Neisseria
polysaccharea)
no annotation 5 LEU A 471
VAL A 622
TYR A 620
GLY A 579
LEU A 361
None
1.08A 6bsiA-5n6vA:
undetectable
6bsiA-5n6vA:
13.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5ovn POL PROTEIN

(Feline
immunodeficiency
virus)
no annotation 6 LEU A  99
LYS A 102
VAL A 105
GLY A 189
LEU A 233
TYR A 317
None
0.79A 6bsiA-5ovnA:
25.8
6bsiA-5ovnA:
50.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5t81 EPOB

(Sorangium
cellulosum)
PF00668
(Condensation)
5 LEU A 474
LYS A 274
VAL A 469
GLY A 468
LEU A 271
None
1.45A 6bsiA-5t81A:
2.1
6bsiA-5t81A:
10.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5v41 POLYKETIDE SYNTHASE
PKS13 (TERMINATION
POLYKETIDE SYNTHASE)


(Mycobacterium
tuberculosis)
PF00975
(Thioesterase)
5 LEU A1518
VAL A1473
VAL A1456
GLY A1499
LEU A1529
None
1.19A 6bsiA-5v41A:
undetectable
6bsiA-5v41A:
14.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5wat HOMOSERINE KINASE

(Corynebacterium
glutamicum)
no annotation 5 LEU A  22
VAL A 298
VAL A 150
GLY A 148
LEU A 273
None
1.49A 6bsiA-5watA:
undetectable
6bsiA-5watA:
25.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6apj ALPHA-N-ACETYLGALACT
OSAMINIDE
ALPHA-2,6-SIALYLTRAN
SFERASE 2


(Homo sapiens)
no annotation 5 LEU A 371
VAL A 153
TYR A 372
TYR A 323
GLY A 155
None
1.46A 6bsiA-6apjA:
undetectable
6bsiA-6apjA:
16.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6en4 SPLICING FACTOR 3B
SUBUNIT 3


(Homo sapiens)
no annotation 5 LEU A 669
VAL A 614
VAL A 588
GLY A 608
LEU A 675
None
1.41A 6bsiA-6en4A:
undetectable
6bsiA-6en4A:
16.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6esq HYDROXYMETHYLGLUTARY
L-COA SYNTHASE


(Methanothermococcus
thermolithotrophicus)
no annotation 5 LEU I 284
VAL I 236
TYR I 234
GLY I 262
TYR I   9
None
1.37A 6bsiA-6esqI:
undetectable
6bsiA-6esqI:
23.60